RCKT

Rocket Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 5/10
  • Value↓ 4/10
Rocket Pharmaceuticals sales and earnings growth
RCKT Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 28.90%
  • FCF Y/Y↑ 15.53%
Rocket Pharmaceuticals gross and profit margin trends
RCKT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -79.21%
Rocket Pharmaceuticals net debt vs free cash flow
RCKT Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -109.7

Rocket Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks